Results 191 to 200 of about 125,515 (216)

Effects of aprocitentan on prognostically relevant ambulatory blood pressure-derived variables in resistant hypertension. [PDF]

J Hypertens
Schlaich MP, Weber MA, Flack JM, Danaietash P, Sassi-Sayadi M, Narkiewicz K, Wang JG.   +6 more
europepmc   +1 more source

From resistant hypertension to renal denervation: an emerging therapeutic approach in light of new international guidelines. [PDF]

Int J Cardiol Cardiovasc Risk Prev
Cordeanu EM, Morisot E, Bronner F, Prinz E, Stephan D.   +4 more
europepmc   +1 more source

Spironolactone vs Amiloride for Resistant Hypertension: A Randomized Clinical Trial.

JAMA
Lee CJ, Ihm SH, Shin DH, Jeong JO, Kim JH, Chun KH, Ryu J, Lee HY, Choi S, Lee EM, Choi JH, Kim KI, Shin J, Pyun WB, Kim DH, Park S, Williams B.   +16 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A Controlled Trial of Renal Denervation for Resistant Hypertension

New England Journal of Medicine, 2014
Barry T Katzen, Minglei Liu, Manuela Negoita   +2 more
exaly  

Ambulatory Blood Pressure Changes After Renal Sympathetic Denervation in Patients With Resistant Hypertension

Circulation, 2013
Felix Mahfoud, Roland E Schmieder, Bodo Cremers   +2 more
exaly  

Resistant Hypertension

Hypertension, 2002
Sandra J Taler
exaly  

Apparent and true resistant hypertension: definition, prevalence and outcomes

Journal of Human Hypertension, 2014
D A Calhoun, Calhoun D A
exaly